查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1424067

细胞治疗市场、份额、规模、趋势、行业分析报告：按治疗类型、按技术、按应用、按地区、按细分市场、预测，2024-2032 年

Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy Type (Allogeneic Therapies and Autologous Therapies); By Technology; By Application; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球细胞治疗市场预计将达到248.5亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

各种慢性疾病的增加、全球政府支持的增加以及大力投资细胞治疗研究和开发的公司的激增正在推动市场的成长。 此外，细胞治疗在个人化医疗、再生医学、免疫治疗等方面的不断扩大的应用也增加了细胞治疗在医疗领域的存在。

例如，2024 年 1 月，Pluri 宣布成立一个名为 "PluriCDMO" 的新部门。 新部门将提供类似合约开发和製造设施的细胞治疗药物製造服务。

此外，对细胞疗法的需求正在迅速增加，仅 2022 年就有约 1,500 项涉及细胞疗法的临床试验在 ClinicalTrials.gov 上註册。 为了满足这种不断增长的需求，公司正在以前所未有的规模生产细胞，同时保持安全、品质和功效。 因此，一次性生物反应器和 3D 生物列印等细胞生产的创新解决方案正在快速推出。

将 3D 生物列印和自动化等先进技术整合到细胞疗法中正在获得巨大的关注。 公司越来越多地寻求将这些技术融入细胞疗法中，因为这些技术的主要目的是提高整体可扩展性、降低营运成本并提供及时且一致的结果。 例如，2023 年 5 月，Cellular Origins 宣布推出 Constellation，这是一个全自动且可设定的机器人平台。 它专门设计用于自动化先进疗法的製造，无需进行大量的製程重新开发。

该市场的驱动因素是CAR-T 细胞疗法的日益普及，以及持续不断的研究工作，重点是增强和改善这些疗法的安全性、有效性以及对更广泛患者群体的使用，正在进一步推动其增长。 例如，2023年12月，Max Healthcare与Immunoact合作在德里一家医院推出了CAR-T细胞疗法。

细胞治疗市场报告亮点

由于遗传疾病治疗的应用不断增加，自体细胞疗法领域将占据最大份额

由于体细胞技术在免疫治疗中的应用越来越多，因此预计该技术将占据很大份额

由于全球疾病的增加和世界的老化，肌肉骨骼领域将以最快的速度增长。

由于大型製药公司的存在和细胞疗法製造流程的进步，北美在全球市场占据主导地位

主要市场参与者包括 Merck KGaA、Precision Biosciences、Becton、Dickinson, and Company、CRISPR Therapeutics 和 Thermo Fisher Scientific。

目录

第1章简介

第 2 章执行摘要

第3章研究方法

第4章全球细胞治疗市场洞察

  • 细胞治疗市场 - 技术概览
  • 细胞治疗市场动态
    • 推动者和机会
      • 对有效或强效治疗的需求不断增长，以及对个人化医疗的接受度不断提高，推动了市场成长
      • 策略伙伴关係和协作可能会推动市场成长
    • 抑制因素和挑战
      • 高昂的开发成本和复杂的製造流程限制了市场成长
  • PESTEL 分析
  • 细胞治疗市场的技术趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第5章全球细胞治疗市场（依应用）

  • 主要发现
  • 简介
  • 肌肉骨骼系统
  • 心血管
  • 胃肠道
  • 神经系统
  • 肿瘤学
  • 皮肤科
  • 伤口
  • 眼科
  • 其他

第 6 章全球细胞治疗市场（依治疗类型）

  • 主要发现
  • 简介
  • 同质疗法
  • 自我治疗

第 7 章全球细胞治疗市场：依技术分类

  • 主要发现
  • 简介
  • 体细胞技术
  • 细胞永生化技术
  • 病毒载体技术
  • 基因组编辑技术
  • 细胞可塑性技术

第 8 章全球细胞治疗市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年细胞治疗市场评估（按地区）
  • 细胞治疗市场 - 北美
    • 北美：细胞治疗市场，依应用划分，2019-2032 年
    • 北美：细胞治疗市场（依技术），2019-2032 年
    • 北美：细胞治疗市场，依治疗类型，2019-2032 年
    • 细胞治疗市场-美国
    • 细胞治疗市场 - 加拿大
  • 细胞治疗市场 - 欧洲
    • 欧洲：细胞治疗市场，依应用划分，2019-2032 年
    • 欧洲：细胞治疗市场（依技术），2019-2032 年
    • 欧洲：细胞治疗市场，依治疗类型，2019-2032 年
    • 细胞治疗市场 - 英国
    • 细胞治疗市场—法国
    • 细胞治疗市场 - 德国
    • 细胞治疗市场—义大利
    • 细胞治疗市场 - 西班牙
    • 细胞治疗市场 - 荷兰
    • 细胞治疗市场—俄罗斯
  • 细胞治疗市场 - 亚太地区
    • 亚太地区：细胞治疗市场，依应用划分，2019-2032 年
    • 亚太地区：细胞治疗市场（依技术），2019-2032 年
    • 亚太地区：细胞治疗市场，依治疗类型，2019-2032 年
    • 细胞治疗市场 - 中国
    • 细胞治疗市场—印度
    • 细胞治疗市场 - 马来西亚
    • 细胞治疗市场—日本
    • 细胞治疗市场—印度尼西亚
    • 细胞治疗市场－韩国
  • 细胞治疗市场 - 中东和非洲
    • 中东和非洲：细胞治疗市场（按应用），2019-2032 年
    • 中东和非洲：细胞治疗市场（按技术），2019-2032 年
    • 中东和非洲：细胞治疗市场（按治疗类型），2019-2032 年
    • 细胞治疗市场－沙乌地阿拉伯
    • 细胞治疗市场 - 阿拉伯联合大公国
    • 细胞治疗市场—以色列
    • 细胞治疗市场 - 南非
  • 细胞治疗市场 - 拉丁美洲
    • 拉丁美洲：细胞治疗市场，按应用划分，2019-2032 年
    • 拉丁美洲：细胞治疗市场（依技术），2019-2032 年
    • 拉丁美洲：细胞治疗市场，依治疗类型，2019-2032 年
    • 细胞治疗市场 - 墨西哥
    • 细胞治疗市场 - 巴西
    • 细胞治疗市场—阿根廷

第9章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第10章公司简介

  • Becton, Dickinson, and Company（US）
  • Bluebird Bio（US）
  • CRISPR Therapeutics（Switzerland）
  • Fate Therapeutics（US）
  • Lonza Group（Switzerland）
  • Merck KGaA（Germany）
  • Novartis AG（Switzerland）
  • Precision BioSciences（US）
  • Regeneron Pharmaceuticals（US）
  • Sartorius AG（Germany）
  • Takeda Pharmaceutical Company（Japan）
  • Thermo Fisher Scientific Inc.（US）
Product Code: PM4331

The global cell therapy market size is expected to reach USD 24.85 billion by 2032, according to a new study by Polaris Market Research. The report "Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy Team (Allogeneic Therapies and Autologous Therapies); By Technology; By Application; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increasing prevalence of various chronic conditions, rising government assistance worldwide, and surge in the number of companies investing heavily in research & development of cell therapies, are driving the market's growth. Additionally, growing applications of cell therapies in personalized medicine, regenerative medicine, and immunotherapy making them more prominent in the medical field.

For instance, in January 2024, Pluri, announced the launch of its new business division named "PluriCDMO". The new business division will offer cell therapy manufacturing services like a contract development and manufacturing organization.

Furthermore, need for the cell therapies is growing drastically and in 2022 only, around 1,500 clinical trials involving cell therapies were registered with the ClinicalTrials.gov. In order to meet this rising demand, companies producing cells at unprecedented scale while maintaining the safety, quality, and efficacy. Thus, the incorporation of innovative solutions in cell production such as single-use bioreactors and 3D bioprinting are emerging at rapid pace.

The integration of advanced technologies like 3D bioprinting and automation into cell therapies is gaining huge traction. As these technologies mainly aimed at improving the overall scalability, reduce operational costs, and ensure timely & consistent delivery of results, companies are increasingly looking to integrate these technologies into their cell therapies. For instance, in May 2023, Cellular Origins, announced the launch of Constellation, a fully automated and configurable robotic platform. It is specially designed to automate the manufacturing of advanced therapies without major process redevelopment.

Growing adoption of CAR-T cell therapies and ongoing research activities focused on enhancing or improving the safety, efficacy, and applications of these therapies for broader patient population, further escalating the market's growth. For instance, in December 2023, Max Healthcare, introduced CAR-T cell therapy in collaboration with the ImmunoACT at its hospital in Delhi.

Cell Therapy Market Report Highlights

Autologous therapies segment accounted for largest share, on account of its increasing adoption for the treatment of genetic disorders

Somatic cell technology segment expected to hold significant share, due to rising usage of this technology in immunotherapies

Musculoskeletal segment will grow at fastest pace, that is attributed to rise in incidences of these conditions worldwide and global aging population

North America dominated the global market, owing to presence of large pharma companies and advancements in cell therapies manufacturing processes

The key market players include Merck KGaA, Precision Biosciences, Becton, Dickinson, and Company, CRISPR Therapeutics, and Thermo Fisher Scientific

Polaris Market Research has segmented the cell therapy market report based on therapy type, technology, application, and region:

Cell Therapy, Therapy Type Outlook (Revenue - USD Billion, 2023 - 2032)

  • Allogeneic Therapies
  • Autologous Therapies

Cell Therapy, Technology Outlook (Revenue - USD Billion, 2023 - 2032)

  • Somatic Cell Technology
  • Cell Immortalization Technology
  • Viral Vector Technology
  • Genome Editing Technology
  • Cell Plasticity Technology

Cell Therapy, Application Outlook (Revenue - USD Billion, 2023 - 2032)

  • Musculoskeletal
  • Cardiovascular
  • Gastrointestinal
  • Neurological
  • Oncology
  • Dermatology
  • Wound and Injuries
  • Ocular
  • Others

Cell Therapy, Regional Outlook (Revenue - USD Billion, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cell Therapy Market Insights

  • 4.1. Cell Therapy Market - Technology Snapshot
  • 4.2. Cell Therapy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing need for effective or potent treatments and rising acceptance of personalized medicine to drive market's growth
      • 4.2.1.2. Strategic Partnerships & collaboration are likely to boost market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High development cost and complex manufacturing process to restrain the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cell Therapy Market Technology Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cell Therapy Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • 5.3. Musculoskeletal
    • 5.3.1. Global Cell Therapy Market, by Musculoskeletal, by Region, 2019-2032 (USD Billion)
  • 5.4. Cardiovascular
    • 5.4.1. Global Cell Therapy Market, by Cardiovascular, by Region, 2019-2032 (USD Billion)
  • 5.5. Gastrointestinal
    • 5.5.1. Global Cell Therapy Market, by Gastrointestinal, by Region, 2019-2032 (USD Billion)
  • 5.6. Neurological
    • 5.6.1. Global Cell Therapy Market, by Neurological, by Region, 2019-2032 (USD Billion)
  • 5.7. Oncology
    • 5.7.1. Global Cell Therapy Market, by Oncology, by Region, 2019-2032 (USD Billion)
  • 5.8. Dermatology
    • 5.8.1. Global Cell Therapy Market, by Dermatology, by Region, 2019-2032 (USD Billion)
  • 5.6. Wound and Injuries
    • 5.6.1. Global Cell Therapy Market, by Wound and Injuries, by Region, 2019-2032 (USD Billion)
  • 5.7. Ocular
    • 5.7.1. Global Cell Therapy Market, by Ocular, by Region, 2019-2032 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Cell Therapy Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Cell Therapy Market, by Therapy Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • 6.3. Allogeneic Therapies
    • 6.3.1. Global Cell Therapy Market, by Allogeneic Therapies, by Region, 2019-2032 (USD Billion)
  • 6.4. Autologous Therapies
    • 6.4.1. Global Cell Therapy Market, by Autologous Therapies, by Region, 2019-2032 (USD Billion)

7. Global Cell Therapy Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • 7.3. Somatic Cell Technology
    • 7.3.1. Global Cell Therapy Market, by Somatic Cell Technology, By Region, 2019-2032 (USD Billion)
  • 7.4. Cell Immortalization Technology
    • 7.4.1. Global Cell Therapy Market, by Cell Immortalization Technology, By Region, 2019-2032 (USD Billion)
  • 7.5. Viral Vector Technology
    • 7.5.1. Global Cell Therapy Market, by Viral Vector Technology, By Region, 2019-2032 (USD Billion)
  • 7.6. Genome Editing Technology
    • 7.6.1. Global Cell Therapy Market, by Genome Editing Technology, By Region, 2019-2032 (USD Billion)
  • 7.7. Cell Plasticity Technology
    • 7.7.1. Global Cell Therapy Market, by Cell Plasticity Technology, By Region, 2019-2032 (USD Billion)

8. Global Cell Therapy Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Cell Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Cell Therapy Market - North America
    • 8.3.1. North America: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.3.2. North America: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
    • 8.3.3. North America: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.3.4. Cell Therapy Market - U.S.
      • 8.3.4.1. U.S.: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.3.5. Cell Therapy Market - Canada
      • 8.3.5.1. Canada: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.4. Cell Therapy Market - Europe
    • 8.4.1. Europe: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.4. Cell Therapy Market - UK
      • 8.4.4.1. UK: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.5. Cell Therapy Market - France
      • 8.4.5.1. France: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.6. Cell Therapy Market - Germany
      • 8.4.6.1. Germany: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.7. Cell Therapy Market - Italy
      • 8.4.7.1. Italy: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.8. Cell Therapy Market - Spain
      • 8.4.8.1. Spain: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.9. Cell Therapy Market - Netherlands
      • 8.4.9.1. Netherlands: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.10. Cell Therapy Market - Russia
      • 8.4.10.1. Russia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.5. Cell Therapy Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.4. Cell Therapy Market - China
      • 8.5.4.1. China: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.5. Cell Therapy Market - India
      • 8.5.5.1. India: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.6. Cell Therapy Market - Malaysia
      • 8.5.6.1. Malaysia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.7. Cell Therapy Market - Japan
      • 8.5.7.1. Japan: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.8. Cell Therapy Market - Indonesia
      • 8.5.8.1. Indonesia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.9. Cell Therapy Market - South Korea
      • 8.5.9.1. South Korea: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.6. Cell Therapy Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.6.4. Cell Therapy Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.6.5. Cell Therapy Market - UAE
      • 8.6.5.1. UAE: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.6.6. Cell Therapy Market - Israel
      • 8.6.6.1. Israel: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.6.7. Cell Therapy Market - South Africa
      • 8.6.7.1. South Africa: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.7. Cell Therapy Market - Latin America
    • 8.7.1. Latin America: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.7.4. Cell Therapy Market - Mexico
      • 8.7.4.1. Mexico: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.7.5. Cell Therapy Market - Brazil
      • 8.7.5.1. Brazil: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.7.6. Cell Therapy Market - Argentina
      • 8.7.6.1. Argentina: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Becton, Dickinson, and Company (US)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bluebird Bio (US)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. CRISPR Therapeutics (Switzerland)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Fate Therapeutics (US)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Lonza Group (Switzerland)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Merck KGaA (Germany)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Novartis AG (Switzerland)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Precision BioSciences (US)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Regeneron Pharmaceuticals (US)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sartorius AG (Germany)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Takeda Pharmaceutical Company (Japan)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Thermo Fisher Scientific Inc. (US)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development

List of Tables

  • Table 1 Global Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 2 Global Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 3 Global Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 4 Cell Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 6 North America: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 7 North America: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 8 U.S.: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 9 U.S.: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 11 Canada: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 12 Canada: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 13 Canada: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 14 Europe: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 15 Europe: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 16 Europe: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 17 UK: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 18 UK: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 19 UK: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 20 France: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 21 France: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 22 France: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 23 Germany: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 24 Germany: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 26 Italy: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 27 Italy: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 28 Italy: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 29 Spain: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 30 Spain: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 31 Spain: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 35 Russia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 36 Russia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 37 Russia: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 41 China: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 42 China: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 43 China: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 44 India: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 45 India: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 46 India: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 50 Japan: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 51 Japan: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 52 Japan: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 56 South Korea: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 57 South Korea: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 58 South Korea: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 65 UAE: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 66 UAE: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 67 UAE: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 68 Israel: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 69 Israel: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 70 Israel: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 71 South Africa: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 72 South Africa: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 73 South Africa: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 74 Latin America: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 75 Latin America: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 76 Latin America: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 77 Mexico: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 78 Mexico: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 79 Mexico: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 80 Brazil: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 81 Brazil: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 83 Argentina: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 84 Argentina: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 85 Argentina: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Cell Therapy Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Therapy Type
  • Figure 7. Global Cell Therapy Market, by Therapy Type, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Cell Therapy Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Technology
  • Figure 11. Global Cell Therapy Market, by Technology, 2022 & 2032 (USD Billion)
  • Figure 12. Cell Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Cell Therapy Market